PriceTargets.com logo

Ryan Specialty - RYAN Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $66.60
  • Forecasted Upside: 18.62%
  • Number of Analysts: 17
  • Breakdown:
  • 1 Sell Ratings
  • 5 Hold Ratings
  • 10 Buy Ratings
  • 1 Strong Buy Ratings
$56.14 As of 12/4/2025 04:59 PM ET
▼ -0.706 (-1.24%)

This chart shows the closing price for RYAN by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Ryan Specialty Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RYAN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RYAN

Analyst Price Target is $66.60
▲ +18.62% Upside Potential
This price target is based on 17 analysts offering 12 month price targets for Ryan Specialty in the last 3 months. The average price target is $66.60, with a high forecast of $76.00 and a low forecast of $60.00. The average price target represents a 18.62% upside from the last price of $56.14.

This chart shows the closing price for RYAN for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 17 investment analysts is to moderate buy stock in Ryan Specialty. This rating has held steady since April 2025, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 1 sell ratings
Ratings as of
6/12/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 6 hold ratings
  • 1 sell ratings
Ratings as of
9/10/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 5 hold ratings
  • 1 sell ratings
Ratings as of
12/9/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 6 hold ratings
  • 1 sell ratings
Ratings as of
3/9/2025
  • 0 strong buy ratings
  • 8 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
6/7/2025
  • 0 strong buy ratings
  • 9 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
9/5/2025
  • 1 strong buy ratings
  • 9 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
11/4/2025
  • 1 strong buy ratings
  • 10 buy ratings
  • 5 hold ratings
  • 1 sell ratings
Ratings as of
12/4/2025

Latest Recommendations

  • 1 strong buy ratings
  • 10 buy ratings
  • 5 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/1/2025Jefferies Financial GroupInitiated CoverageHold$64.00
11/26/2025Jefferies Financial GroupSet Target$76.00
11/26/2025CowenReiterated RatingBuy ➝ Buy
11/26/2025TD CowenLower TargetBuy ➝ Buy$89.00 ➝ $76.00
11/20/2025BarclaysLower TargetOverweight ➝ Overweight$70.00 ➝ $65.00
11/20/2025Piper SandlerInitiated CoverageNeutral$60.00
11/17/2025Morgan StanleyBoost TargetOverweight ➝ Overweight$65.00 ➝ $67.00
11/3/2025BMO Capital MarketsLower TargetOutperform ➝ Outperform$70.00 ➝ $66.00
11/3/2025Keefe, Bruyette & WoodsLower TargetOutperform ➝ Outperform$73.00 ➝ $65.00
10/31/2025The Goldman Sachs GroupLower TargetBuy ➝ Buy$71.00 ➝ $63.00
10/9/2025JPMorgan Chase & Co.Lower TargetUnderweight ➝ Underweight$64.00 ➝ $63.00
10/8/2025UBS GroupLower TargetBuy ➝ Buy$80.00 ➝ $75.00
10/8/2025BarclaysReiterated RatingOverweight ➝ Overweight$70.00
10/8/2025Weiss RatingsReiterated RatingHold (C-) ➝ Hold (C-)
10/8/2025Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$60.00 ➝ $64.00
10/7/2025Morgan StanleyLower TargetOverweight ➝ Overweight$68.00 ➝ $65.00
9/27/2025Weiss RatingsReiterated RatingHold (C-) ➝ Hold (C-)
9/17/2025Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$60.00
9/16/2025Wolfe ResearchUpgradeStrong-Buy
9/15/2025Wolfe ResearchInitiated CoveragePeer Perform ➝ Outperform$64.00
8/18/2025Morgan StanleyLower TargetOverweight ➝ Overweight$71.00 ➝ $68.00
8/13/2025Cantor FitzgeraldUpgradeHold
8/13/2025CitigroupInitiated CoverageBuy$74.00
8/12/2025Cantor FitzgeraldInitiated CoverageNeutral$61.00
8/8/2025Morgan StanleyLower TargetOverweight ➝ Overweight$78.00 ➝ $71.00
8/4/2025UBS GroupLower TargetBuy ➝ Buy$84.00 ➝ $80.00
8/1/2025Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$63.00 ➝ $60.00
7/14/2025Morgan StanleyLower TargetOverweight ➝ Overweight$80.00 ➝ $78.00
7/10/2025Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$65.00 ➝ $63.00
7/7/2025BarclaysLower TargetOverweight ➝ Overweight$83.00 ➝ $79.00
5/19/2025Morgan StanleyBoost TargetOverweight ➝ Overweight$78.00 ➝ $80.00
5/13/2025The Goldman Sachs GroupUpgradeNeutral ➝ Buy$74.00 ➝ $81.00
4/11/2025BarclaysLower TargetOverweight ➝ Overweight$88.00 ➝ $83.00
4/10/2025Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$69.00 ➝ $66.00
4/10/2025TD CowenInitiated CoverageBuy$89.00
4/9/2025Keefe, Bruyette & WoodsLower TargetOutperform ➝ Outperform$76.00 ➝ $75.00
2/26/2025UBS GroupBoost TargetBuy ➝ Buy$82.00 ➝ $84.00
2/21/2025Royal Bank Of CanadaLower TargetSector Perform ➝ Sector Perform$73.00 ➝ $72.00
2/21/2025Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$64.00 ➝ $69.00
2/21/2025Keefe, Bruyette & WoodsLower TargetOutperform ➝ Outperform$77.00 ➝ $76.00
1/14/2025Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$68.00 ➝ $64.00
1/10/2025Keefe, Bruyette & WoodsLower TargetOutperform ➝ Outperform$79.00 ➝ $77.00
12/5/2024Morgan StanleyInitiated CoverageOverweight$90.00
11/21/2024BarclaysBoost TargetOverweight ➝ Overweight$76.00 ➝ $88.00
10/10/2024Bank of AmericaBoost TargetBuy ➝ Buy$75.00 ➝ $84.00
10/10/2024Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$63.00 ➝ $70.00
10/9/2024The Goldman Sachs GroupBoost TargetNeutral ➝ Neutral$64.00 ➝ $72.00
9/24/2024BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$65.00 ➝ $75.00
9/4/2024BarclaysInitiated CoverageOverweight$76.00
8/13/2024UBS GroupBoost TargetBuy ➝ Buy$67.00 ➝ $76.00
8/5/2024The Goldman Sachs GroupBoost TargetNeutral ➝ Neutral$58.00 ➝ $64.00
8/2/2024JPMorgan Chase & Co.Boost TargetUnderweight ➝ Underweight$54.00 ➝ $56.00
8/2/2024Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$60.00 ➝ $63.00
7/23/2024CitigroupBoost TargetNeutral ➝ Neutral$56.00 ➝ $62.00
7/11/2024JPMorgan Chase & Co.Boost TargetUnderweight ➝ Underweight$49.00 ➝ $54.00
7/11/2024Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$58.00 ➝ $60.00
7/9/2024UBS GroupBoost TargetBuy ➝ Buy$63.00 ➝ $67.00
7/2/2024Keefe, Bruyette & WoodsReiterated RatingOutperform ➝ Outperform$62.00 ➝ $62.00
5/22/2024Bank of AmericaInitiated CoverageBuy$67.00
5/6/2024Wolfe ResearchDowngradeOutperform ➝ Peer Perform
4/15/2024JMP SecuritiesReiterated RatingMarket Perform
4/11/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$57.00 ➝ $58.00
4/10/2024Keefe, Bruyette & WoodsBoost TargetOutperform ➝ Outperform$56.00 ➝ $62.00
4/8/2024JPMorgan Chase & Co.Boost TargetUnderweight ➝ Underweight$47.00 ➝ $49.00
2/28/2024CitigroupBoost TargetNeutral ➝ Neutral$49.00 ➝ $52.00
2/28/2024Keefe, Bruyette & WoodsBoost TargetOutperform ➝ Outperform$55.00 ➝ $56.00
2/28/2024JPMorgan Chase & Co.Boost TargetUnderweight ➝ Underweight$44.00 ➝ $47.00
11/20/2023The Goldman Sachs GroupDowngradeBuy ➝ Neutral$57.00 ➝ $53.00
10/30/2023BMO Capital MarketsDowngradeOutperform ➝ Market Perform$53.00 ➝ $49.00
10/10/2023CitigroupBoost TargetNeutral ➝ Neutral$48.00 ➝ $49.00
9/21/2023Wolfe ResearchInitiated CoverageOutperform$59.00
9/19/2023JMP SecuritiesInitiated CoverageMarket Perform
8/4/2023Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$50.00 ➝ $53.00
8/4/2023BarclaysBoost TargetOverweight ➝ Overweight$51.00 ➝ $52.00
7/6/2023JPMorgan Chase & Co.Boost Target$39.00 ➝ $43.00
5/5/2023Wells Fargo & CompanyBoost Target$49.00 ➝ $50.00
4/18/2023CitigroupBoost Target$44.00 ➝ $45.00
3/1/2023Wells Fargo & CompanyBoost TargetOverweight$47.00 ➝ $49.00
1/19/2023BMO Capital MarketsInitiated CoverageOutperform$51.00
1/18/2023Wells Fargo & CompanyBoost TargetOverweight$45.00 ➝ $47.00
12/16/2022Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$41.00 ➝ $45.00
12/14/2022CitigroupInitiated CoverageNeutral$42.00
11/16/2022UBS GroupLower Target$48.00
11/16/2022BarclaysLower Target$49.00
11/11/2022Royal Bank Of CanadaLower TargetSector Perform$47.00 ➝ $46.00
11/11/2022Wells Fargo & CompanyLower TargetEqual Weight$44.00 ➝ $41.00
11/11/2022JPMorgan Chase & Co.Lower Target$40.00 ➝ $39.00
10/3/2022JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$40.00
8/15/2022BarclaysBoost Target$51.00
8/12/2022Royal Bank Of CanadaDowngradeOutperform ➝ Sector Perform$42.00 ➝ $47.00
7/12/2022The Goldman Sachs GroupUpgradeNeutral ➝ Buy$47.00
3/16/2022Royal Bank Of CanadaBoost TargetOutperform$40.00 ➝ $42.00
3/16/2022Wells Fargo & CompanyLower TargetEqual Weight$41.00 ➝ $38.00
1/6/2022JPMorgan Chase & Co.Boost Target$33.00 ➝ $34.00
1/6/2022BarclaysBoost TargetOverweight ➝ Overweight$43.00 ➝ $44.00
1/4/2022Wells Fargo & CompanyBoost TargetEqual Weight$37.00 ➝ $41.00
11/12/2021Royal Bank Of CanadaBoost TargetPositive ➝ Outperform$35.00 ➝ $40.00
11/12/2021Wells Fargo & CompanyBoost TargetEqual Weight$33.00 ➝ $37.00
8/20/2021William BlairInitiated CoverageOutperform
8/16/2021Wolfe ResearchInitiated CoverageMarket Perform$32.00
8/16/2021JPMorgan Chase & Co.Initiated CoverageNeutral$31.00
8/16/2021UBS GroupInitiated CoverageBuy$36.00
8/16/2021Royal Bank Of CanadaInitiated CoverageOutperform$34.00
8/16/2021The Goldman Sachs GroupInitiated CoverageNeutral$33.00
8/16/2021BarclaysInitiated CoverageOverweight$35.00
8/16/2021Keefe, Bruyette & WoodsInitiated CoverageOutperform$35.00
8/16/2021Wells Fargo & CompanyInitiated CoverageEqual Weight$31.00
(Data available from 12/5/2020 forward)

News Sentiment Rating

0.91 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 38 very positive mentions
  • 18 positive mentions
  • 3 negative mentions
  • 2 very negative mentions
Mentions as of
5/9/2025
  • 41 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
6/8/2025
  • 15 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/8/2025
  • 35 very positive mentions
  • 19 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
8/7/2025
  • 30 very positive mentions
  • 11 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
Mentions as of
9/6/2025
  • 16 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
10/6/2025
  • 23 very positive mentions
  • 21 positive mentions
  • 9 negative mentions
  • 0 very negative mentions
Mentions as of
11/5/2025
  • 28 very positive mentions
  • 13 positive mentions
  • 6 negative mentions
  • 0 very negative mentions
Mentions as of
12/5/2025

Current Sentiment

  • 28 very positive mentions
  • 13 positive mentions
  • 6 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Ryan Specialty logo
Ryan Specialty Holdings, Inc. operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter. The company serves commercial, industrial, institutional, and government sectors. Ryan Specialty Holdings, Inc. was founded in 2010 and is headquartered in Chicago, Illinois.
Read More

Today's Range

Now: $56.14
Low: $55.11
High: $57.51

50 Day Range

MA: $55.68
Low: $50.86
High: $58.38

52 Week Range

Now: $56.14
Low: $50.08
High: $77.16

Volume

1,373,117 shs

Average Volume

1,044,885 shs

Market Capitalization

$14.81 billion

P/E Ratio

122.05

Dividend Yield

0.84%

Beta

0.62

Frequently Asked Questions

What sell-side analysts currently cover shares of Ryan Specialty?

The following sell-side analysts have issued stock ratings on Ryan Specialty in the last twelve months: Barclays PLC, BMO Capital Markets, Cantor Fitzgerald, Citigroup Inc., Cowen Inc, Jefferies Financial Group Inc., JPMorgan Chase & Co., Keefe, Bruyette & Woods, Morgan Stanley, Piper Sandler, Royal Bank Of Canada, TD Cowen, The Goldman Sachs Group, Inc., UBS Group AG, Wall Street Zen, Weiss Ratings, Wells Fargo & Company, and Wolfe Research.
View the latest analyst ratings for RYAN.

What is the current price target for Ryan Specialty?

0 Wall Street analysts have set twelve-month price targets for Ryan Specialty in the last year. Their average twelve-month price target is $66.60, suggesting a possible upside of 18.6%. TD Cowen has the highest price target set, predicting RYAN will reach $76.00 in the next twelve months. Piper Sandler has the lowest price target set, forecasting a price of $60.00 for Ryan Specialty in the next year.
View the latest price targets for RYAN.

What is the current consensus analyst rating for Ryan Specialty?

Ryan Specialty currently has 1 sell rating, 5 hold ratings, 10 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for RYAN.

What other companies compete with Ryan Specialty?

Other companies that are similar to Ryan Specialty include Arthur J. Gallagher & Co., Manulife Financial, Prudential Public, Sun Life Financial and Willis Towers Watson Public. Learn More about companies similar to Ryan Specialty.

How do I contact Ryan Specialty's investor relations team?

The company's listed phone number is 312-784-6001 and its investor relations email address is [email protected]. The official website for Ryan Specialty is ryansg.com. Learn More about contacing Ryan Specialty investor relations.